Free Trial

Ekso Bionics Q1 2024 Earnings Report

Ekso Bionics logo
$0.55 -0.01 (-2.60%)
As of 02/21/2025 03:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Ekso Bionics EPS Results

Actual EPS
-$0.20
Consensus EPS
-$0.16
Beat/Miss
Missed by -$0.04
One Year Ago EPS
-$0.33

Ekso Bionics Revenue Results

Actual Revenue
$3.76 million
Expected Revenue
$4.99 million
Beat/Miss
Missed by -$1.23 million
YoY Revenue Growth
N/A

Ekso Bionics Announcement Details

Quarter
Q1 2024
Time
After Market Closes

Ekso Bionics Earnings Headlines

StockNews.com Begins Coverage on Ekso Bionics (NASDAQ:EKSO)
Ekso Bionics names NSM as Ekso Indego Personal device distributor
$5,000 DOGE check?
Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.
See More Ekso Bionics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Ekso Bionics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ekso Bionics and other key companies, straight to your email.

About Ekso Bionics

Ekso Bionics (NASDAQ:EKSO) designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

View Ekso Bionics Profile

More Earnings Resources from MarketBeat